How small would the sample size have to be before you would consider trying the drug yourself, just to see if you, too, lived forever as long as you took it?
Reducing sample size also blinds you to any ill effects the drug might have. If you’re looking to generalize your idea about outliers, immortality seems to be an especially poor example since it’s more unusual than any real outlier you might come across.
As far as I know, psychiatrists cannot reliably predict that a given drug will improve a patient’s long-term diagnosis, and psychiatrists/psychologists cannot even reliably agree on what condition a patient is manifesting.
Taboo reliable. How would scrutinizing outliers make them more reliable? Acknowledging people are unique snowflakes doesn’t help if you have no tools to know when and how they’re unique. Other specialties have the same problem, psychiatrists’ tools are just especially crude in comparison.
Mental disorders appear to resist diagnosis and solution, unlike, say, a broken leg or a sucking chest wound
Substitute those surgical conditions with some endocrine condition for example and the contrast may not be so stark.
If you’re treating yourself, you’re especially prone to bias. Doctors acknowledge this and many think they shouldn’t treat themselves. If you want to utilize outliers, at least have someone else do or confirm the research. Doesn’t have to be a doctor if you don’t trust them.
Taboo reliable. Sure. I hold the opinion that psychiatrists cannot predict that a given drug will improve a patient’s long-term diagnosis, and that psychiatrists/psychologists cannot agree on what condition a patient is manifesting. I agree that we have no tools to know when or how they’re unique. I’m taking the perspective that the (admittedly very biased individual) should consider trying available options with low entry costs and demonstrably unimportant side effects, to see if they are unique snowflakes like those few in the study. The costs seem low and the potential upside high when considering psychological augmentation via off-prescription nootropics.
Good point on the endocrine condition. Very similar situation to what i’m trying to express. Probably a better example than mine.
I’m trying to figure out if bias in the case of the consumer who doesn’t have access to prescription medication is enough, if you have a perspective of ‘try the otc thing to see if you get the same positive outlier result, if not, discontinue.’
Reducing sample size also blinds you to any ill effects the drug might have. If you’re looking to generalize your idea about outliers, immortality seems to be an especially poor example since it’s more unusual than any real outlier you might come across.
Taboo reliable. How would scrutinizing outliers make them more reliable? Acknowledging people are unique snowflakes doesn’t help if you have no tools to know when and how they’re unique. Other specialties have the same problem, psychiatrists’ tools are just especially crude in comparison.
Substitute those surgical conditions with some endocrine condition for example and the contrast may not be so stark.
If you’re treating yourself, you’re especially prone to bias. Doctors acknowledge this and many think they shouldn’t treat themselves. If you want to utilize outliers, at least have someone else do or confirm the research. Doesn’t have to be a doctor if you don’t trust them.
Taboo reliable. Sure. I hold the opinion that psychiatrists cannot predict that a given drug will improve a patient’s long-term diagnosis, and that psychiatrists/psychologists cannot agree on what condition a patient is manifesting. I agree that we have no tools to know when or how they’re unique. I’m taking the perspective that the (admittedly very biased individual) should consider trying available options with low entry costs and demonstrably unimportant side effects, to see if they are unique snowflakes like those few in the study. The costs seem low and the potential upside high when considering psychological augmentation via off-prescription nootropics.
Good point on the endocrine condition. Very similar situation to what i’m trying to express. Probably a better example than mine.
I’m trying to figure out if bias in the case of the consumer who doesn’t have access to prescription medication is enough, if you have a perspective of ‘try the otc thing to see if you get the same positive outlier result, if not, discontinue.’